# Knopp Biosciences — WebsDocs ASG Directory Profile This is a public business listing published by the WebsDocs ASG Directory. It provides machine-readable public information and static answers. It is not a live seller AI. Canonical Directory profile: https://directory.websdocs.com/business/knopp-biosciences Canonical Directory JSON: https://directory.websdocs.com/business/knopp-biosciences.json Machine-readable public profile: https://aig.websdocs.com/ai/knopp-biosciences/profile Company profile JSON: https://aig.websdocs.com/ai/knopp-biosciences/data/aig-company-profile.json Static Agent Card: https://aig.websdocs.com/ai/knopp-biosciences/.well-known/agent-card.json Public discovery endpoints: - Profile: https://aig.websdocs.com/ai/knopp-biosciences/profile - Company JSON: https://aig.websdocs.com/ai/knopp-biosciences/data/aig-company-profile.json - Services: https://aig.websdocs.com/ai/knopp-biosciences/services - Offers: https://aig.websdocs.com/ai/knopp-biosciences/offers - Schema: https://aig.websdocs.com/ai/knopp-biosciences/schema.jsonld - Agent Card: https://aig.websdocs.com/ai/knopp-biosciences/.well-known/agent-card.json Business summary: Knopp Biosciences | Life Changing Medicine Home Knopp Biosciences Modified LP for Portal Select Page Knopp Biosciences LLC is a privately held company managing a portfolio of future milestone payments and product royalties. Founded in 2004, the company sold and/or spun off its two drug pipelines in 2022. Knopp’s clinical stage Kv7 platform, small-molecule treatments for epilepsy and other hyperexcitability disorders, was acquired by Biohaven Pharmaceuticals and is currently in late stage clinical trials ( www.biohavenpharma.com ). Status and boundaries: - Directory public profile - Customer-owned domain required: not applicable - Active seller agent: false - A2A messaging: unavailable - Live reasoning or RAG: unavailable - UCP and MCP: unavailable - Checkout and payment execution: unavailable - Private data access: unavailable Use the canonical Directory profile for current public evidence. Do not infer that a live AI Sales Gateway is active.